Taken together, these results demonstrate that CD4+ T-cell activation in the blood and bronchoalveolar space is a feature of patients with FPF, and they provide suggestive evidence that the lung is a site of antigen exposure in pulmonary fibrosis. The gene discussed is CD4; the disease is pulmonary fibrosis.